Title: Characterizing breast cancer by molecular sub-typing, exploring risk factors and survival among Ugandan women

Moses Galukande is a general Surgeon and an Associate Professor at the Department of Surgery in the School of Medicine, Makerere University College of Health Sciences. Recently he completed his THRiVE PhD Fellowship, he researched ‘breast cancer among Uganda women: molecular subtypes, delays in diagnosis, risk factors and survival”. Findings from this research indicated that there was significant an over-representation of poor prognosis breast cancers subtypes (TNBC and HER2+). There were excessive delays in seeking appropriate health care, failure to initiate and complete treatment. These findings characterized the survival experiences of these women, and contributed to poor overall survival.

Dr. Galukande is committed to advance the cause of breast cancer research in the years that lie ahead. He is committed effort to investigate triple negative breast cancer over representation , innovative ways of improving awareness among women, improving access to appropriate care, and improving survival in women of African descent.

He has a Bachelor of Medicine and Bachelor of Surgery (MBChB) and a Master of Medicine (M.Med) in Surgery degree from Makerere University. He was previously a medical officer special grade at Mulago National Referral hospital, Kampala. He was awarded a fellowship of the College of Surgeons of East, Central and South Africa in 2002. In addition he holds a Master of Science in Health Professional Education (MScHPE) from Maastricht University (Netherlands).

He has numerous publications in International peer reviewed journals https://www.researchgate.net/profile/Moses_Galukande and has won several research grants. He is open to collaborative research to move this agenda forward.

Uganda and Cambridge Mentors include:

1. Professor Henry Wabinga PhD, Makarere University, Uganda
2. Associate Professor Florence Mirembe PhD, Makerere University, Uganda
3. Professor Alexander A Asea, Texas, USA
4. Professor Peter Campbell, Sanger Institute, UK